Fuan Pharmaceutical's (SHE:300194) wholly-owned subsidiary, Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical, will invest 428 million yuan for the construction of an active pharmaceutical ingredient production base, according to a Shenzhen Stock Exchange filing on Wednesday.
The production base will produce 173.9 tons of raw materials every year.
The facility will include a production plant, a solid warehouse and an office building that will be built with estimated total construction area of 38,800 square meters, the pharmaceutical company said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。